Robert E. Rydell

2.2k citations
23 papers · 1.8k · 1 hit paper · h-index 16

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Carcinogens and Genotoxicity Assessment 10
    • Acute Myeloid Leukemia Research 6
    • Chronic Myeloid Leukemia Treatments 2

Robert E. Rydell

22 papers receiving 1.6k citations

Robert E. Rydell's Hit Papers

Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases 1981 · 799 citations
7990+15+30Years since publication250500750

Peers

Robert E. Rydell
Comparison fields: 5 of 69
  • Hematology 1.1k
  • Genetics 182
  • Hepatology 130
  • Cancer Research 114
  • Pharmacology 73
Replace Dan Ayers with:
Dan Ayers United States
Michel Flesch France
Robert W. Talley United States
Daniel E. Bergsagel Canada
Henry E. Wilson United States
Elke Fritz Austria
Donna M. Weber United States
MARCEL KRULIK France
Don V. Jackson United States
Diane L. Warren United States
Robert E. Rydell relative to Dan Ayers United States Dan Ayers's profile →
Citations per field
00.5×2×2.7×
Dan Ayers · 1×
Citations per year

Countries citing papers authored by Robert E. Rydell

Since Specialization
Citations

This map shows the geographic impact of Robert E. Rydell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Rydell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Rydell more than expected).

Fields of papers citing papers by Robert E. Rydell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Rydell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Rydell. The network helps show where Robert E. Rydell may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert E. Rydell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert E. Rydell Line = papers co-authored together Robert E. Rydell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases
Hit paper breakdown →
1981799
2 1988198
3 1956185
4 1980121
5 1983118
6 199185
7 197367
8
On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
197257
9
Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.
199228
10
Structure-activity relationships of N-acylarylhydroxylamines in the rat.
197027
11 198627
12 198020
13
Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
197719
14 197819
15 198118
16
Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids.
197317
17 197311
18
Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo.
197110
19
The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
197510
20 19786

About Robert E. Rydell

Robert E. Rydell is a scholar working on Cancer Research, Hematology, Genetics, Pharmacology and Hepatology, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (10 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Acute Lymphoblastic Leukemia research (1 paper), Vascular Anomalies and Treatments (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Hematology (1.1k citations), Genetics (182 citations), Hepatology (130 citations), Cancer Research (114 citations) and Pharmacology (73 citations). Robert E. Rydell has collaborated with scholars based in United States. Frequent co-authors include Risa B. Mann, Costan W. Berard, Richard S. Neiman, John M. Bennett, Maurice P Barcos, Hugh Bonner, Frederick W. Hoffbauer, Martin M. Oken, Kathy Foucar and Danuta Malejka‐Giganti. Their work appears in journals such as JNCI Journal of the National Cancer Institute, American Journal of Hematology, The American Journal of Medicine, British Journal of Haematology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact